ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 72 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $364,000 | +54.2% | 19,283 | -3.8% | 0.00% | – |
| Q2 2019 | $236,000 | -16.6% | 20,039 | -3.3% | 0.00% | – |
| Q1 2019 | $283,000 | -23.1% | 20,731 | -42.3% | 0.00% | – |
| Q4 2018 | $368,000 | -29.9% | 35,941 | +14.1% | 0.00% | – |
| Q3 2018 | $525,000 | +5.8% | 31,507 | +0.3% | 0.00% | – |
| Q2 2018 | $496,000 | +24.9% | 31,398 | +0.5% | 0.00% | – |
| Q1 2018 | $397,000 | +145.1% | 31,236 | +120.8% | 0.00% | – |
| Q4 2017 | $162,000 | -5.8% | 14,146 | +0.7% | 0.00% | – |
| Q3 2017 | $172,000 | -96.2% | 14,041 | -96.4% | 0.00% | -100.0% |
| Q2 2017 | $4,494,000 | -45.0% | 392,545 | +0.0% | 0.00% | -66.7% |
| Q1 2017 | $8,165,000 | +2.2% | 392,535 | +2.2% | 0.00% | 0.0% |
| Q4 2016 | $7,989,000 | -36.5% | 384,095 | +0.0% | 0.00% | -25.0% |
| Q3 2016 | $12,584,000 | +7.8% | 384,005 | -17.9% | 0.00% | 0.0% |
| Q2 2016 | $11,676,000 | -3.6% | 467,573 | -5.5% | 0.00% | -20.0% |
| Q1 2016 | $12,113,000 | -45.8% | 494,588 | -26.8% | 0.01% | -44.4% |
| Q4 2015 | $22,332,000 | +2.5% | 676,122 | +1.6% | 0.01% | 0.0% |
| Q3 2015 | $21,791,000 | -31.5% | 665,173 | +10.7% | 0.01% | -25.0% |
| Q2 2015 | $31,817,000 | +81.5% | 600,642 | -1.1% | 0.01% | +71.4% |
| Q1 2015 | $17,533,000 | +1485.3% | 607,533 | +1498.6% | 0.01% | – |
| Q4 2014 | $1,106,000 | – | 38,004 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $34,629,000 | 11.36% |
| Foresite Capital Management II, LLC | 1,586,220 | $18,670,000 | 10.50% |
| DAFNA Capital Management LLC | 636,013 | $7,486,000 | 2.81% |
| Redmile Group, LLC | 8,244,896 | $97,042,000 | 2.75% |
| Lion Point Capital, LP | 1,204,600 | $14,178,000 | 1.40% |
| Palo Alto Investors LP | 1,861,630 | $21,911,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,517,856 | $41,405,000 | 0.87% |
| Bellevue Group AG | 4,118,806 | $48,478,000 | 0.83% |
| Rock Springs Capital Management LP | 1,562,300 | $18,388,000 | 0.66% |
| Artal Group S.A. | 850,000 | $10,005,000 | 0.40% |